An interventional study of Inspiratory muscle training and Conventional physical therapy in Burn, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Pulmonary dysfunction can be developed as a result of complications caused by direct thermal injury to the respiratory tract, smoke irritations, and respiratory tract infection. Although the survival rates of patients with burn injury have increased because of improved acute management, pulmonary complications have continued to be the main cause of mortality in patients with burns. The patients who survive suffer from persistent physiological impairments, limited aerobic capacity, increased skeletal muscle catabolism, and decreased muscle strength/endurance. Rehabilitation strategies for the long-term recovery in patients with burns aim to improve the physical function and independence in daily activities.
730 studies on the registry are indexed under Burns; 146 are open to participants now.
This study's planned enrollment of 60 is above the median of 40 across 534 interventional studies indexed under Burns.
Browse Burns studies →Cairo University is the lead sponsor of 4,907 studies on the registry; 1,445 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will receive Inspiratory muscle training followed by conventional physical therapy program
Device: Inspiratory muscle training · Other: Conventional physical therapy
Participants will receive conventional physical therapy program (respiratory physical therapy, balance and aerobic exercises)
Other: Conventional physical therapy
Participants in the experimental group will receive Inspiratory muscle training device, in addition to conventional physical therapy program. Initially, participants will be asked to perform three sets of 30 breaths on the POWER breathe to adjust the load and become familiar with the device. The training will include six 30-breath sets each day, divided into two sessions each. There is a one-minute rest time between each set. The inspiratory muscle load for training will be 50% of maximum inspiratory pressure (MIP), and it will be reviewed and changed weekly.
Conventional physical therapy exercise program in the form of respiratory physical therapy, balance and aerobic exercises.
Respiratory muscle strength (Maximum Inspiratory Pressure)
Maximum Inspiratory Pressure (MIP): Inspiratory muscle strength will be assessed by measuring the maximum inspiratory pressure (MIP) using a respiratory pressure meter. MIP will be recorded in cmH₂O, with higher values indicating greater inspiratory muscle strength.
Time frame: 8 weeks
Respiratory muscle strength (Maximum expiratory Pressure)
Maximum Expiratory Pressure (MEP): Expiratory muscle strength will be assessed by measuring the maximum expiratory pressure (MEP) using a respiratory pressure meter. MEP will be recorded in cmH₂O, with higher values indicating greater expiratory muscle strength.
Time frame: 8 weeks
Balance
Static and dynamic balance of the participants will be assessed through the Berg Balance Scale (BBS) where the patient has to perform 14 predetermined physical tasks assessing different aspects of balance. These include static, anticipatory, dynamic and sensory balance. Each task will be scored from 0 to 4 where 4 indicates the person can complete the task independently with a final maximal score of 56. Higher scores indicate better balance performance.
Time frame: 8 weeks
Postural stability (Overall Stability Index)
Overall Stability Index (OSI): Postural stability will be assessed using the Biodex Postural Stability System (Biodex Medical Systems, Shirley, NY, USA). The Overall Stability Index (OSI) will be recorded as an indicator of overall postural stability, with lower values indicating better stability.
Time frame: 8 weeks
Postural stability (Anterior-Posterior Index)
Anterior-Posterior Index (API): The Anterior-Posterior Stability Index (API) will be measured using the Biodex Postural Stability System (Biodex Medical Systems, Shirley, NY, USA) to assess postural stability in the anterior-posterior direction. Lower values indicate better stability.
Time frame: 8 weeks
Postural stability (Mediolateral Index)
Mediolateral Index (MLI): The Mediolateral Stability Index (MLI) will be measured using the Biodex Postural Stability System (Biodex Medical Systems, Shirley, NY, USA) to assess postural stability in the mediolateral direction. Lower values indicate better stability.
Time frame: 8 weeks
Plan to share: Yes
Supporting information: Study protocol
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Apr 2027, 6 months after the start.
Of 188 non-industry interventional studies with no phase under Burns, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 39. This study's planned 6 months is below that.
Counting every sponsor, half of 204 studies reached it within 18 months; a quarter within 7 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.